Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System

Zhang, Hongwei, Yang, Bin, Mu, Xin, Ahmed, Seemin Seher, Su, Qin, He, Ran, Wang, Hongyan, Mueller, Christian +4 more·2011·Molecular Therapy

Cited by (291)

Items 101–200 of 291

  1. Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
    Xu, Liang, Yao, Shun, Ding, Yifan Evan, Xie, Mengxiao, Feng, Dingqi, Sha, Pengfei, Tan, Lu, Bei, Fengfeng, Yao, Yizheng · 2024 · Journal of Translational Medicine
  2. Cryo-electron Microscopy of Adeno-associated Virus
    Scott M. Stagg, Craig Yoshioka, Omar Davulcu, Michael Stewart Chapman · 2022 · Chemical Reviews
  3. Mouse Gender Influences Brain Transduction by Intravascularly Administered AAV9
    Casey A. Maguire, Matheus H. W. Crommentuijn, Dakai Mu, Eloïse Hudry, Alberto Serrano‐Pozo, Bradley T. Hyman, Bakhos A. Tannous · 2013 · Molecular Therapy
  4. Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats
    Juliette Hordeaux, Laurence Dubreil, Johan Deniaud, Fabien Iacobelli, Stéphanie Moreau, Mireille Ledevin, Caroline Le Guiner, Véronique Blouin, Johanne Le Duff, Alexandra Mendes-Madeira et al. · 2015 · Gene Therapy
  5. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features
    Mohammad A. Rafi, Han Zhi Rao, Paola Luzi, Alice Luddi, Mark T. Curtis, David A. Wenger · 2014 · Molecular Genetics and Metabolism
  6. Extracting structural and functional features of widely distributed biological circuits with single cell resolution via tissue clearing and delivery vectors
    Jennifer B. Treweek, Viviana Gradinaru · 2016 · Current Opinion in Biotechnology
  7. Delivering gene therapy for mucopolysaccharide diseases
    Shaun Wood, Brian Bigger · 2022 · Frontiers in Molecular Biosciences
  8. Epigenetic Treatment of Neurological Disease
    Steven G. Gray · 2011 · Epigenomics
  9. Gene Therapy Strategies to Restore ER Proteostasis in Disease
    Vicente Valenzuela, Kasey L. Jackson, S. Pablo Sardi, Claudio A. Hetz · 2018 · Molecular Therapy
  10. Structural and cellular biology of adeno-associated virus attachment and entry
    James R. Zengel, Jan E. Carette · 2020 · Advances in virus research
  11. AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice
    Shilpa Prabhakar, Sevda Lüle, Cintia Carla da Hora, Xandra O. Breakefield, Pike-See Cheah · 2021 · EXPERIMENTAL ANIMALS
  12. Intravenous rAAV2/9 injection for murine cochlear gene delivery
    Seiji Bruce Shibata, Hidekane Yoshimura, Paul T. Ranum, Alexander T. Goodwin, Richard J. Smith · 2017 · Scientific Reports
  13. Translating CRISPR-Cas Therapeutics: Approaches and Challenges
    Lavina Sierra Tay, Nathan D. Palmer, Rebecca Panwala, Wei Leong Chew, Prashant Mali · 2020 · The CRISPR Journal
  14. Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
    Lalitha R. Belur, Megan Romero, Junggu Lee, Kelly M. Podetz-Pedersen, Zhenhong Nan, Maureen S. Riedl, Lucy Vulchanova, Kelley F. Kitto, Carolyn A. Fairbanks, Karen Kozarsky et al. · 2021 · Frontiers in Molecular Neuroscience
  15. Advances in AAV technology for delivering genetically encoded cargo to the nonhuman primate nervous system
    Lillian Campos, Cynthia Mary Arokiaraj, Miguel R. Chuapoco, Xinhong Chen, Nick Goeden, Viviana Gradinaru, Andrew S. Fox · 2023 · Current Research in Neurobiology
  16. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury
    Hayk A. Petrosyan, Valentina Alessi, V Singh, Arsen S. Hunanyan, Joel M. Levine, Victor L. Arvanian · 2014 · Gene Therapy
  17. Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model
    Allison M. Keeler, Marina Zieger, C. Semple, Logan A. Pucci, Alessandra Veinbachs, Robert H. Brown, C. Mueller, M. ElMallah · 2019 · Molecular Therapy: Methods & Clinical Development
  18. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD
    Wang, Jing-Zhang, Wu, Peng, Shi, Zhi-Min, Xu, Yan-Li, Liu, Zhi-Jun · 2017 · Brain and Development
  19. Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor
    Qing Xie, Xiupeng Chen, Hong Ma, Yunxiang Zhu, Yijie Ma, Leila Jalinous, Gerald F. Cox, Fiona Weaver, Jun Yang, Zachary Kennedy et al. · 2024 · EMBO Molecular Medicine
  20. Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
    Kai Zhou, Jinming Han, Yafeng Wang, Yaodong Zhang, Changlian Zhu · 2022 · Frontiers in Molecular Neuroscience
  21. Adeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics
    Jun Xie, Daniel Robert Burt, Guangping Gao · 2015 · Seminars in Liver Disease
  22. MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy
    Naemeh Pourshafie, Philip R. Lee, Ke‐lian Chen, George G. Harmison, Laura C. Bott, Masahisa Katsuno, Gen Sobue, Barrington G. Burnett, Kenneth H. Fischbeck, Carlo Rinaldi · 2016 · Molecular Therapy
  23. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders
    Maria Sara Cipolat Mis, Simona Brajkovic, Francesco Tafuri, Nereo Bresolin, Giacomo P. Comi, Stefania Paola Corti · 2016 · Molecular Neurobiology
  24. AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice
    Arpad Palfi, Naomi Chadderton, Sophia Millington‐Ward, Iris J. M. Post, Pete Humphries, Paul F. Kenna, Gwyneth Jane Farrar · 2022 · Molecular Therapy — Methods & Clinical Development
  25. Update of treatment for Gaucher disease
    Weijing Kong, Cheng Lu, Yingxue Ding, Yan Meng · 2022 · European Journal of Pharmacology
  26. Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects
    Żaneta Słyk, Natalia Stachowiak, Maciej Małecki · 2024 · Biomedicines
  27. Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy
    Judit Homs, Gemma Pagès, Lorena Ariza, Caty Casas, Miguel Chillón, Xavier Navarro, Assumpció Bosch · 2014 · Molecular Therapy — Methods & Clinical Development
  28. Gene therapy to target ER stress in brain diseases
    Vicente Valenzuela, Gabriela Martínez, Claudia A. Duran-Aniotz, Claudio A. Hetz · 2016 · Brain Research
  29. Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery
    Alexia Kagiava, Jan Richter, Christina Tryfonos, Marc Leal-Julià, Irene Sargiannidou, Christina Christodoulou, Assumpció Bosch, Kleopas A. Kleopa · 2021 · Scientific Reports
  30. Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
    Lars Matthias Ittner, Matthias Klugmann, Yazi Diana Ke · 2019 · British Journal of Pharmacology
  31. Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
    Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, Paras Famta, Saurabh Srivastava, Shashi Bala Singh, Dharmendra Kumar Khatri · 2023 · Mechanisms of Ageing and Development
  32. Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques
    Benjamin Dehay, Deniz Dalkara, Sandra Doveró, Qin Li, Erwan Bézard · 2012 · Scientific Reports
  33. Taming microglia: the promise of engineered microglia in treating neurological diseases
    Echo Yongqi Luo, Ryohichi Sugimura · 2024 · Journal of Neuroinflammation
  34. A Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord
    Yansu Guo, Dan Wang, Tao Qiao, Chunxing Yang, Qin Su, Guangping Gao, Zuoshang Xu · 2015 · Molecular Neurobiology
  35. Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9
    Barbara Commisso, Lingjun Ding, Karl Varadi, Martin Gorges, David Bayer, Tobias M. Boeckers, Albert Christian Ludolph, Jan Kassubek, Oliver Josef Müller, Francesco Roselli · 2018 · eLife
  36. A next step in adeno‐associated virus‐mediated gene therapy for neurological diseases: regulation and targeting
    Abdelwahed Chtarto, Olivier Bockstael, Térence Tshibangu, O. Dewitte, Marc Levivier, Liliane Tenenbaum · 2013 · British Journal of Clinical Pharmacology
  37. Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?
    Ashley L. Harkins, Prajakta Prasad Ambegaokar, Allison M. Keeler · 2024 · Neurotherapeutics
  38. Gene Transfer to the CNS Using Recombinant Adeno‐Associated Virus
    Lorelei Stoica, Seemin Seher Ahmed, Guangping Gao, Miguel Sena‐Esteves · 2013 · Current Protocols in Microbiology
  39. Drug Delivery Strategies to Overcome the Blood–Brain Barrier (BBB)
    Hans Christian Cederberg Helms, Mie Kristensen, Lasse Saaby, Gert Fricker, Birger Brodin · 2020 · Handbook of experimental pharmacology
  40. Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
    Yi Chen, Guiquan Wang, Jingqiao Chen, Congying Wang, Xi Dong, Hsun‐Ming Chang, Shuai Yuan, Yue Zhao, Liangshan Mu · 2024 · Endocrine Reviews
  41. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice
    Xiufang Pan, Scott A. Sands, Yongping Yue, Keqing Zhang, Steven M. LeVine, Dongsheng Duan · 2019 · Human Gene Therapy
  42. Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich’s Ataxia
    Anusha Sivakumar, Stéphanie Cherqui · 2022 · Frontiers in Genome Editing
  43. Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies
    Yu-Shan Tseng, Kim Van Vliet, Lavanya Rao, ROBERT V. McKENNA, Barry J. Byrne, Aravind Asokan, Mavis Agbandje‐McKenna · 2016 · Journal of Virological Methods
  44. A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
    Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, Pan Zhu, Xuehua Pan, Meilan Wei, Peng George Wang, Yang Ji, Dimitri Papukashvili · 2024 · International Journal of Biological Sciences
  45. Extracellular vesicles containing the transferrin receptor as nanocarriers of apotransferrin
    Vanesa Soledad Mattera, Pehuén Pereyra Gerber, Romina Julieta Glisoni, Matías Ostrowski, Sandra Viviana Verstraeten, Juana Maria Pasquini, Jorge Daniel Correale · 2020 · Journal of Neurochemistry
  46. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
    Cheng‐Pu Sun, Jia‐Tsrong Jan, I-Hsuan Wang, Hsiu‐Hua Ma, Hui‐Ying Ko, Ping‐Yi Wu, Tzu-Jiun Kuo, Hsin-Ni Liao, Yu-Hua Lan, Zong‐Lin Sie et al. · 2021 · PLoS Pathogens
  47. Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders
    Dominic J. Gessler, Guangping Gao · 2015 · Methods in molecular biology
  48. In vivo methods for acute modulation of gene expression in the central nervous system
    Andrzej W. Cwetsch, Bruno Pinto, Annalisa Savardi, Laura Cancedda · 2018 · Progress in Neurobiology
  49. Studying ALS: Current Approaches, Effect on Potential Treatment Strategy
    Elizaveta Ustyantseva, Sergey P. Medvedev, Suren M. Zakian · 2020 · Advances in experimental medicine and biology
  50. Modulating the Excitability of Olfactory Output Neurons Affects Whole-Body Metabolism
    Louis John Kolling, Roberta Tatti, Troy W. Lowry, Ashley M. Loeven, James M. Fadool, Debra Ann Fadool · 2022 · Journal of Neuroscience
  51. SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research
    Anthony Lima, Danilo Maddalo · 2021 · Frontiers in Oncology
  52. Bioderived Nanoparticles for Cardiac Repair
    Xiaolin Cui, Jiacheng Guo, Peiyu Yuan, Yichen Dai, Pengchong Du, Fengyi Yu, Zhaowei Sun, Jinying Zhang, Ke Cheng, Junnan Tang · 2024 · ACS Nano
  53. Broad Functional Correction of Molecular Impairments by Systemic Delivery of scAAVrh74-hSGSH Gene Delivery in MPS IIIA Mice
    Duncan, F Jason, Naughton, Bartholomew J, Zaraspe, Kimberly, Murrey, Darren A, Meadows, Aaron S, Clark, Kelly Reed, Newsom, David E, White, Peter, Fu, Haiyan, McCarty, Douglas M · 2015 · Molecular Therapy
  54. Live-Animal Epigenome Editing: Convergence of Novel Techniques
    J. Antonio Gomez, Ulrika Beitnere, David Jay Segal · 2019 · Trends in Genetics
  55. The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
    Ye Yuan, Lihong Wang, Xianxian Zhao, Jiao Wang, Mengsi Zhang, Qinghua Ma, Sen Wei, Zexuan Yan, Yue Cheng, Xiao‐Qing Chen et al. · 2022 · 癌症:英文版
  56. Intracranial AAV‐sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma
    Matheus H. W. Crommentuijn, Casey A. Maguire, Johanna M. Niers, William Peter Vandertop, Christian E. Badr, Thomas D. Wurdinger, Bakhos A. Tannous · 2015 · Molecular Oncology
  57. rAAV Gene Therapy in a Canavan’s Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System
    Ahmed, Seemin Seher, Schattgen, Stefan A, Frakes, Ashley E, Sikoglu, Elif M, Su, Qin, Li, Jia, Hampton, Thomas G, Denninger, Andrew R, Kirschner, Daniel A, Kaspar, Brian et al. · 2016 · Molecular Therapy
  58. Gene therapy for the neurological manifestations in lysosomal storage disorders
    Seng H. Cheng · 2014 · Journal of Lipid Research
  59. Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain
    Sandro Alves, Julia Bode, Alexis‐Pierre Bemelmans, Christof V. Kalle, Nathalie Cartier, Björn Tews · 2016 · Scientific Reports
  60. Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
    Lorelei Stoica, Miguel Sena‐Esteves · 2016 · Frontiers in Molecular Neuroscience
  61. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy
    Deirdre M. A. O’Connor, Nicholas M. Boulis · 2012 · Neuroscience Letters
  62. Aspartylglucosaminuria: Clinical Presentation and Potential Therapies
    Kimberly Goodspeed, Cynthia Feng, Minna Laine, Troy C. Lund · 2021 · Journal of Child Neurology
  63. Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders
    Abhik Paul, Michael G. Collins, Hye Young Lee · 2022 · Frontiers in Genome Editing
  64. Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders
    Cintia Elisabeth Gomez Limia, Megan Baird, Maura Schwartz, Smita Saxena, Kathrin Meyer, Nicolas Wein · 2022 · Journal of Personalized Medicine
  65. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9
    Zheng Chai, Xintao Zhang, Amanda Lee Dobbins, Kelly Michelle Rigsbee, Bing Wang, Richard Jude Samulski, Chengwen Li · 2019 · Human Gene Therapy
  66. Perinatal systemic gene delivery using adeno-associated viral vectors
    Rajvinder Karda, Suzanne M. K. Buckley, Citra Nurfarah Zaini Mattar, Joanne Ng, Giulia Massaro, Michael P. Hughes, Manju A. Kurian, Julien Baruteau, Paul Gissen, Jerry Kok Yen Chan et al. · 2014 · Frontiers in Molecular Neuroscience
  67. Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
    Livia Zhou, Yafeng Wang, Yiran Xu, Yaodong Zhang, Changlian Zhu · 2024 · Molecular Therapy — Methods & Clinical Development
  68. Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3 Mashl/+ , Mouse Model of Alternating Hemiplegia of Childhood
    Arsen S. Hunanyan, Boris Kantor, Ram S. Puranam, Courtney Elliott, Angela L. McCall, Justin S. Dhindsa, Promila Pagadala, Keri Wallace, Jordan Poe, Talha Gunduz et al. · 2021 · Human Gene Therapy
  69. Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges
    Amina Abulimiti, Michael Siu‐Lun Lai, Raymond Chuen‐Chung Chang · 2021 · Mechanisms of Ageing and Development
  70. Pilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
    Marie-Laure Arotçarena, Sandra Doveró, Nathalie Biendon, Nathalie Dutheil, Vincent Planche, Erwan Bézard, Benjamin Dehay · 2021 · Frontiers in Bioengineering and Biotechnology
  71. Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus–α-L-Iduronidase for Hurler Disease
    Christopher G. Janson, Liudmila G. Romanova, Paola Leone, Zhenhong Nan, Lalitha R. Belur, R. Scott McIvor, Walter C. Low · 2013 · Neurosurgery
  72. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis
    Amanda L. Gross, Heather L. Gray‐Edwards, Cassie N Bebout, Nathan L. Ta, Kayly Nielsen, Brandon L. Brunson, Kalajan R Lopez Mercado, Devin E. Osterhoudt, Ana Rita Batista, Stacy A. Maitland et al. · 2021 · Brain
  73. In Vivo Astrocytic Ca 2+ Signaling In Health and Brain Disorders
    Shinghua Ding · 2013 · Future Neurology
  74. Moving toward a gene therapy for Huntington’s disease
    Glorioso, J C, Cohen, J B, Carlisle, D L, Munoz-Sanjuan, I, Friedlander, R M · 2015 · Gene Therapy
  75. RNA activation of haploinsufficient Foxg1 gene in murine neocortex
    Cristina Fimiani, Elisa Goina, Qin Su, Guangping Gao, Antonello Mallamaci · 2016 · Scientific Reports
  76. Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
    Lalitha R. Belur, Kelly M. Podetz-Pedersen, Thuy An Tran, Joshua A. Mesick, Nathaniel M. Singh, Maureen S. Riedl, Lucy Vulchanova, Karen Kozarsky, R. Scott McIvor · 2020 · Molecular Genetics and Metabolism Reports
  77. Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model
    Shilpa Prabhakar, Xuan Zhang, June Goto, Sangyeul Han, Charles Pin‐Kuang Lai, Roderick Terry Bronson, Miguel Sena‐Esteves, Vijaya Ramesh, Anat O Stemmer-Rachamimov, David J. Kwiatkowski et al. · 2015 · Neurobiology of Disease
  78. PhP.B Enhanced Adeno-Associated Virus Mediated-Expression Following Systemic Delivery or Direct Brain Administration
    Kimberly L. Pietersz, Francois Du Plessis, Stephan M. Pouw, Jolanda M.P. Liefhebber, Sander J. H. van Deventer, Gerard J.M. Martens, Pavlina S. Konstantinova, Bas Blits · 2021 · Frontiers in Bioengineering and Biotechnology
  79. Cell Reprogramming for Regeneration and Repair of the Nervous System
    Isaac H. Clark, Alex Roman, Emily Fellows, Swathi Radha, Susanna R. Var, Zachary Roushdy, Samuel M. Borer, Samantha Johnson, Olivia M. Chen, Jacob S.W. Borgida et al. · 2022 · Biomedicines
  80. Emerging trends in virus and virus-like particle gene therapy delivery to the brain
    Heshadi Primrose Primrose Mandalawatta, Rajendra KC, Kirsten A. Fairfax, Alex William Hewitt · 2024 · Molecular Therapy — Nucleic Acids
  81. Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood
    Margriet A. van Gestel, Arjen J. Boender, Véronne A. J. de Vrind, Keith M. Garner, Mieneke C. M. Luijendijk, Roger A.H. Adan · 2014 · PLoS ONE
  82. Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
    Ferrantelli, Flavia, Chiozzini, Chiara, Leone, Patrizia, Manfredi, Francesco, Federico, Maurizio · 2020 · Pharmaceutics
  83. Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain
    Jennifer S. Katz, Hasan Slika, Shahab Aldin Sattari, Adarsha P. Malla, Yuanxuan Xia, Albert Antar, Kathleen Renee Ran, Betty Tyler · 2025 · ACS Omega
  84. Structural Study of Aavrh.10 Receptor and Antibody Interactions
    Mario Mietzsch, Jennifer C. Yu, Jane Hsi, Paul R. Chipman, Felix Broecker, Zhang Fuming, Robert J. Linhardt, Peter H. Seeberger, Regine Heilbronn, Robert McKenna et al. · 2021 · Journal of Virology
  85. Intrathecal Injection of scAAV9–hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway
    Haojie Hu, Huiqian Lin, WeiSong Duan, Can Cui, Zhongyao Li, Yakun Liu, Wan Wang, Di Wen, Ying Wang, Chunyan Li · 2018 · Neuroscience
  86. Unique Glycan Signatures Regulate Adeno-Associated Virus Tropism in the Developing Brain
    Giridhar Murlidharan, Travis Corriher, H. Troy Ghashghaei, Aravind Asokan · 2015 · Journal of Virology
  87. Intralingual Administration of AAVrh10-miR SOD1 Improves Respiratory But Not Swallowing Function in a Superoxide Dismutase-1 Mouse Model of Amyotrophic Lateral Sclerosis
    Lori A. Lind, Ellyn Andel, Angela L. McCall, Justin S. Dhindsa, Katherine A. Johnson, Olivia E. Stricklin, Christian Mueller, Mai K. ElMallah, Teresa E. Lever, Nicole Louise Nichols · 2020 · Human Gene Therapy
  88. Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors
    Josephine Macdonald, Jennifer Marx, Hildegard Büning · 2021 · Human Gene Therapy
  89. Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials.
    Metovic, Jasna, Li, Yedda, Gong, Yi, Eichler, Florian · 2024 · Neurotherapeutics
  90. Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy
    Stolte, Benjamin, Schreiber-Katz, Olivia, Günther, René, Wurster, Claudia Diana, Petri, Susanne, Osmanovic, Alma, Freigang, Maren, Uzelac, Zeljko, Leo, Markus, von Velsen, Otgonzul et al. · 2022 · Human Gene Therapy
  91. Preventing and treating neurotrophic keratopathy by a single intrastromal injection of AAV-mediated gene therapy
    Lin Cong, Benxiang Qi, Wenhui Ma, Zhongmei Ren, Qian Liang, Qingjun Zhou, Bi Ning Zhang, Lixin Xie · 2024 · The Ocular Surface
  92. Efficiency of cell-type specific and generic promoters in transducing oxytocin neurons and monitoring their neural activity during lactation
    Keerthi Thirtamara Rajamani, Amanda B. Leithead, Michelle Kim, Marie Barbier, Michael Peruggia, Kristi Niblo, Lara Barteczko, Arthur Lefèvre, Valery Grinevich, Hala Harony‐Nicolas · 2021 · Scientific Reports
  93. AAV-mediated FOXG1 gene editing in human Rett primary cells
    Susanna Croci, Miriam Lucia Carriero, Katia Capitani, Sergio Daga, Francesco Donati, Filomena Tiziana Papa, Elisa Frullanti, Diego Lopergolo, Vittoria Lamacchia, Rossella Tita et al. · 2020 · European Journal of Human Genetics
  94. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages
    Macarena Calero, Lara H. Moleiro, Aline Sayd, Yeray Dorca, Lluís Miquel-Rio, Verónica Paz, Javier Robledo‐Montaña, E. Enciso, F. Acción, Diego Herráez‐Aguilar et al. · 2022 · Frontiers in Molecular Biosciences
  95. Developing therapies for spinal muscular atrophy
    Mary H. Wertz, Mustafa Şahin · 2015 · Annals of the New York Academy of Sciences
  96. Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems
    Zahoor Ahmad Shah, Daniyah A. Almarghalani, Sai H. S. Boddu, Mohammad Ali, Akhila Kondaka, Devin Ta, RayyanA Shah · 2021 · Neural Regeneration Research
  97. Structure of the AAVhu.37 capsid by cryoelectron microscopy
    Jason T. Kaelber, Samantha A. Yost, Keith Webber, Emre Firlar, Ye Liu, Olivier Danos, Andrew C. Mercer · 2020 · Acta Crystallographica Section F Structural Biology Communications
  98. An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism
    Nengsong Luo, Kunzhang Lin, Yuxiang Cai, Zilian Zhang, Xiaokai Sui, Zengpeng Han, Wenjia Yuan, Jiayong Xing, Zhu Gui, Gangning Liu et al. · 2025 · Journal of Controlled Release
  99. Optogenetic manipulation of ENS - The brain in the gut
    Wei Wang · 2017 · Life Sciences
  100. Finding the Striatum in Sheep: Use of a Multi-Modal Guided Approach for Convection Enhanced Delivery
    I.M.J. van der Bom, R.P. Moser, Guangping Gao, Elisabetta Mondo, D. C. O'Connell, Matthew J. Gounis, S. McGowan, Joanna Chaurette, Nina Bishop, Miguel Sena‐Esteves et al. · 2013 · Journal of Huntington s Disease